	Number			Weighted average exercise price		Weighted average remaining contractual life (years)		Aggregate intrinsic value (in thousands)
Options outstanding as of December 31, 2025	52,450			$	13.86	9.43		$	-
Granted	212,692			6.53		-		-
Exercised		-			-		-		-
Forfeited		(3	)		2,142		-		-
Options outstanding as of March 31, 2026		265,139		$	10.41		9.83	$	21

Options exercisable as of March 31, 2026		364		$	1,979.98		0.21	$	-

Schedule of options and RSUs outstanding

Range of exercise price	Options and RSUs outstanding as of March 31, 2026	Weighted average remaining contractual life (years) (1)	Options outstanding and exercisable as of March 31, 2026	Weighted average remaining contractual life (years) (1)
RSUs only	107,781	-	-	-
$6.53	212,692	9.99	-	-
$8.6	18,750	9.38	-	-
$14.70	33,333	9.18	-	-
$450.70	147	-	147	-
$2,257.5-$18,270	217	0.35	217	0.35
	372,920	9.83	364	0.21

(1)

Calculation of weighted average remaining contractual term does not include the RSUs that were granted, which have an indefinite contractual term.

Schedule of warrants outstanding and exercisable

Issuance date	Warrants outstanding		Exercise price per warrant		Warrants outstanding and exercisable		Contractual term
	(number)				(number)
December 8, 2020 (1)	6,984		$	112.56		6,984		June 8, 2026
December 8, 2020 (2)		1,294	$	150.54		1,294		June 8, 2026
February 26, 2021 (3)		64,998	$	302.40		64,998		August 26, 2026
February 26, 2021 (4)		7,800	$	384.56		7,800		August 26, 2026
September 29, 2021 (5)		95,314	$	168.00		95,314		March 29, 2027
September 29, 2021 (6)		11,437	$	213.68		11,437		September 27, 2026
January 8, 2025 (7)		151,514	$	33.00		151,514		January 10, 2028
January 8, 2025 (8)		9,088	$	41.25		9,088		January 10, 2028
June 26, 2025 (9)		333,328	$	7.8		333,328		June 26, 2030
June 26, 2025 (10)		20,000	$	9.75		20,000		June 26, 2030
		701,757				701,757

(1)

Represents warrants that were issued to certain institutional purchasers in a private placement in the Company’s private placement offering of ordinary shares in December 2020. As of March 31, 2026, 42,834 warrants were exercised for a total consideration of $4,821,416. During the three months that ended March 31, 2026, no warrants were exercised.

(2)

Represents warrants that were issued to the placement agent as compensation for its role in the Company’s December 2020 private placement. As of March 31, 2026, 2,690 warrants were exercised for a total consideration of $405,003. During the three months that ended March 31, 2026, no warrants were exercised.

(3)

Represents warrants that were issued to certain institutional purchasers in a private placement in the Company’s private placement offering of ordinary shares in February 2021.

(4)

Represents warrants that were issued to the placement agent as compensation for its role in the Company’s February 2021 private placement.

(5)

Represents warrants that were issued to certain institutional purchasers in a private placement in the Company’s registered direct offering of ordinary shares in September 2021.

(6)

Represents warrants that were issued to the placement agent as compensation for its role in the Company’s September 2021 registered direct offering.

(7)

Represents warrants that were issued to certain institutional purchasers in a private placement in the Company’s registered direct offering of ordinary shares in January 2025.

(8)

Represents warrants that were issued to the placement agent as compensation for its role in the Company’s January 2025 registered direct offering.

(9)

Represents warrants that were issued to certain institutional investors in connection with the Company’s public offering of ordinary shares in June 2025.

(10)

Represents warrants that were issued to the placement agent as compensation for its role in the Company’s public offering of ordinary shares in June 2025.